1-63323419-G-A

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2

The NM_012183.3(FOXD3):​c.361G>A​(p.Gly121Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000233 in 1,547,066 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000017 ( 0 hom. )

Consequence

FOXD3
NM_012183.3 missense

Scores

2
1
16

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.08
Variant links:
Genes affected
FOXD3 (HGNC:3804): (forkhead box D3) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct forkhead domain. Mutations in this gene cause autoimmune susceptibility 1. [provided by RefSeq, Nov 2008]
FOXD3-AS1 (HGNC:40241): (FOXD3 antisense RNA 1)
ITGB3BP (HGNC:6157): (integrin subunit beta 3 binding protein) This gene encodes a transcriptional coregulator that binds to and enhances the activity of members of the nuclear receptor families, thyroid hormone receptors and retinoid X receptors. This protein also acts as a corepressor of NF-kappaB-dependent signaling. This protein induces apoptosis in breast cancer cells through a caspase 2-mediated signaling pathway. This protein is also a component of the centromere-specific histone H3 variant nucleosome associated complex (CENP-NAC) and may be involved in mitotic progression by recruiting the histone H3 variant CENP-A to the centromere. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Sep 2011]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.030260712).
BS2
High AC in GnomAd4 at 12 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FOXD3NM_012183.3 linkc.361G>A p.Gly121Ser missense_variant Exon 1 of 1 ENST00000371116.4 NP_036315.1 Q9UJU5
FOXD3-AS1NR_121636.1 linkn.185+72C>T intron_variant Intron 1 of 2
FOXD3-AS1NR_121637.1 linkn.87+936C>T intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FOXD3ENST00000371116.4 linkc.361G>A p.Gly121Ser missense_variant Exon 1 of 1 6 NM_012183.3 ENSP00000360157.2 Q9UJU5

Frequencies

GnomAD3 genomes
AF:
0.0000791
AC:
12
AN:
151786
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.0000833
AC:
15
AN:
179980
AF XY:
0.0000497
show subpopulations
Gnomad AFR exome
AF:
0.000496
Gnomad AMR exome
AF:
0.000455
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000172
AC:
24
AN:
1395170
Hom.:
0
Cov.:
33
AF XY:
0.0000173
AC XY:
12
AN XY:
692106
show subpopulations
African (AFR)
AF:
0.000378
AC:
11
AN:
29130
American (AMR)
AF:
0.000344
AC:
12
AN:
34898
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24044
East Asian (EAS)
AF:
0.00
AC:
0
AN:
33574
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79354
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50212
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4234
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1082398
Other (OTH)
AF:
0.0000174
AC:
1
AN:
57326
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.567
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000790
AC:
12
AN:
151896
Hom.:
0
Cov.:
33
AF XY:
0.0000404
AC XY:
3
AN XY:
74242
show subpopulations
African (AFR)
AF:
0.000217
AC:
9
AN:
41480
American (AMR)
AF:
0.000131
AC:
2
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5140
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10540
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67854
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.000117
ESP6500AA
AF:
0.000268
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.0000751
AC:
9

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 17, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.361G>A (p.G121S) alteration is located in exon 1 (coding exon 1) of the FOXD3 gene. This alteration results from a G to A substitution at nucleotide position 361, causing the glycine (G) at amino acid position 121 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.088
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Benign
0.24
T
Eigen
Benign
-0.84
Eigen_PC
Benign
-0.79
FATHMM_MKL
Benign
0.29
N
LIST_S2
Benign
0.30
T
M_CAP
Pathogenic
0.40
D
MetaRNN
Benign
0.030
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.55
N
PhyloP100
2.1
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
0.52
N
REVEL
Benign
0.18
Sift
Benign
0.39
T
Sift4G
Benign
0.29
T
Polyphen
0.055
B
Vest4
0.18
MVP
0.29
ClinPred
0.017
T
GERP RS
2.6
Varity_R
0.069
gMVP
0.43
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201881536; hg19: chr1-63789090; API